Literature DB >> 28633317

Discussion: The FDA is Unprepared for Personalized Medicine.

Alex Tabarrok1.   

Abstract

Mesh:

Year:  2017        PMID: 28633317     DOI: 10.1093/biostatistics/kxx018

Source DB:  PubMed          Journal:  Biostatistics        ISSN: 1465-4644            Impact factor:   5.899


× No keyword cloud information.
  2 in total

1.  The FDA and the COVID-19: A political economy perspective.

Authors:  Raymond J March
Journal:  South Econ J       Date:  2021-02-28

2.  Perceptions of Regulatory Decision-Making for New Drugs From the Viewpoints of the Manufacturers in South Korea.

Authors:  Kyung-Bok Son; Sylvia Park
Journal:  Front Med (Lausanne)       Date:  2022-03-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.